Cann Group Ltd (ASX: CAN) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Cann Group Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $22.05 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 468.94 million
Earnings per share -0.072
Dividend per share N/A
Year To Date Return -60.82%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Cann Group Ltd (ASX: CAN)
    Latest News

    a woman
    ⏸️ Investing

    Why I think Auscann Group Holdings Ltd is the best pot stock to buy

    Aussie pot stocks have been on a tear. Over the last 6 months alone Hydroponics Company Ltd (ASX:THC) and Auscann…

    Read more »

    a woman
    ⏸️ Investing

    These pot stocks have been on fire in 2018

    The Auscann Group Holdings Ltd (ASX:AC8) share price is up 120% so far in 2018…

    Read more »

    a woman
    ⏸️ Investing

    Why the pot stocks crashed lower

    The Cann Group Ltd (ASX:CAN) share price was one of seven in the pot stock industry sinking lower…

    Read more »

    a woman
    ⏸️ Investing

    These pot stocks have gone gangbusters in 2018

    The Auscann Group Holdings Ltd (ASX:AC8) share price has been one of the biggest movers on the market in 2018…

    Read more »

    a woman
    ⏸️ Investing

    Why BOD Australia Ltd jumped 40% in a day

    This company enjoyed massive gains on Thursday. Here’s more…

    Read more »

    a woman
    ⏸️ Investing

    ALL ORDINARIES finishes higher Thursday: 10 shares you missed

    The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished higher on Thursday.

    Read more »

    a woman
    ⏸️ Investing

    Why these 4 ASX shares pushed higher today

    The Cann Group Ltd (ASX:CAN) share price is one of four pushing notably higher on Thursday. Here’s why…

    Read more »

    a woman
    ⏸️ Investing

    Why Cann Group Ltd shares jumped 35% to a record-high today

    The Cann Group Ltd (ASX:CAN) share price has been a huge mover on Thursday. Here’s why…

    Read more »

    a woman
    ⏸️ Investing

    Pot stocks rocket on regulation change

    The Cann Group Ltd (ASX: CAN) share price is one of a number in the pot stock industry smoking the…

    Read more »

    a woman
    ⏸️ Investing

    Why Aussie pot stocks are smoking the market today

    The Auscann Group Holdings Ltd (ASX:AC8) share price is one of a number in the pot stock industry smoking the…

    Read more »

    a woman
    ⏸️ Investing

    ALL ORDINARIES finishes higher Thursday: 7 shares you missed

    The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished higher on Thursday.

    Read more »

    a woman
    ⏸️ Investing

    Pot stocks are flying high today

    The Auscann Group Holdings Ltd (ASX:AC8) share price is one of six flying higher in the pot stock industry today…

    Read more »

    CAN ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Cann Group Ltd

    Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the company; the development and manufacture (via third party arrangements) of finished product formulations; and the pursuit and execution of various supply and offtake agreements with third parties.

    CAN Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    22 Nov 2024 $0.05 $0.00 0.00% 252,920 $0.05 $0.05 $0.05
    21 Nov 2024 $0.05 $0.00 0.00% 98,577 $0.05 $0.05 $0.05
    20 Nov 2024 $0.05 $0.00 0.00% 153,301 $0.05 $0.05 $0.05
    19 Nov 2024 $0.05 $0.00 0.00% 286,446 $0.05 $0.05 $0.05
    18 Nov 2024 $0.05 $0.00 0.00% 361,218 $0.05 $0.05 $0.05
    15 Nov 2024 $0.05 $0.00 0.00% 469,832 $0.05 $0.05 $0.05
    14 Nov 2024 $0.05 $0.00 0.00% 433,663 $0.05 $0.05 $0.05
    13 Nov 2024 $0.05 $0.00 0.00% 562,307 $0.05 $0.05 $0.05
    12 Nov 2024 $0.05 $0.00 0.00% 505,862 $0.05 $0.05 $0.05
    11 Nov 2024 $0.05 $0.00 0.00% 645,595 $0.05 $0.05 $0.05
    08 Nov 2024 $0.05 $0.00 0.00% 372,076 $0.05 $0.06 $0.05
    07 Nov 2024 $0.05 $0.00 0.00% 2,238,930 $0.05 $0.06 $0.05
    06 Nov 2024 $0.05 $0.00 0.00% 362,819 $0.05 $0.05 $0.05
    05 Nov 2024 $0.05 $0.00 0.00% 283,767 $0.05 $0.05 $0.05
    04 Nov 2024 $0.05 $0.00 0.00% 1,162,609 $0.05 $0.05 $0.04
    01 Nov 2024 $0.04 $0.00 0.00% 323,897 $0.04 $0.04 $0.04
    31 Oct 2024 $0.04 $0.00 0.00% 320,557 $0.04 $0.04 $0.04
    30 Oct 2024 $0.04 $0.00 0.00% 89,278 $0.04 $0.04 $0.04
    29 Oct 2024 $0.04 $0.00 0.00% 1,716,579 $0.04 $0.04 $0.04
    28 Oct 2024 $0.04 $0.00 0.00% 575,002 $0.04 $0.04 $0.04
    25 Oct 2024 $0.04 $0.00 0.00% 1,117,082 $0.04 $0.04 $0.04
    24 Oct 2024 $0.04 $0.00 0.00% 936,306 $0.04 $0.04 $0.04

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    15 Nov 2024 Douglas (Doug) Rathbone Issued 300,000 $13,500
    Issue of securities.
    15 Nov 2024 Julian Chick Issued 600,000 $27,000
    Issue of securities.
    15 Nov 2024 Jennifer (Jenni) Pilcher Issued 4,500,000 $202,500
    Issue of securities.
    15 Nov 2024 Robert Barnes Issued 300,000 $13,500
    Issue of securities.
    12 Jun 2024 Jennifer (Jenni) Pilcher Buy 205,500 $9,952
    On-market trade.
    05 Jun 2024 Robert Barnes Buy 200,000 $10,000
    On-market trade.
    04 Jun 2024 Julian Chick Buy 250,000 $10,000
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Douglas (Doug) John Rathbone Non-Executive Director Mar 2015
    Mr Rathbone is a public company director. He is the Chairman of the Rathbone Wine Group, Director of Cotton Seed Distributors, Go Resources, AgBiTech. He is also a Chairman of Health Food Holdings and Delta Agribusiness Pty Ltd. Doug is an Honorary Life Governor of the Royal Children's Hospital. He is President of My Room Children's Cancer Charity Limited and founder of Children's Cancer Foundation.
    Mr Allan D McCallum Non-Executive ChairmanNon-Executive Director Jan 2015
    Mr McCallum has experience as a public company director in agribusiness and healthcare who has ethics, leadership capabilities and experience in strategy development and implementation, and mergers and acquisitions. Allan is also a member of Rabobank Australia Limited's Advisory Board (wholesale banking).
    Dr Julian John Chick Non-Executive DirectorNon-Executive Deputy Chairman Oct 2022
    Dr Chick has over 25 years of experience in the biotechnology and medical technology sectors, as well as in investment banking. He has worked with public and private companies, bringing several technologies through from discovery to market, as well as experience in capital raisings, company restructuring, licensing, business development and M&A transactions. He is a member of the Risk Committee.
    Ms Jennifer (Jenni) Pilcher Chief Executive OfficerManaging Director Sep 2020
    Ms Pilchers has over 15 years of senior finance executive experience in the medical, biotechnology and technology sectors, within small-mid cap ASX-listed companies. In addition to financial management, investor relations and corporate governance experience. Most recently, Jenni was Chief Financial Officer & Company Secretary of technology communications company Whispir Ltd (ASX:WSP), and prior to that was CFO & Company Secretary of digital imaging company, Mach7 Technologies (ASX:M7T). She has also previously held CFO roles with Australia biotechnology companies Alchemia Limited (ASX:ACL) and Mesoblast Limited (ASX:MSB).
    Mr Robert Gordon Barnes Non-Executive Director Sep 2022
    Mr Barnes is an executive who has delivered leadership and operational outcomes across a variety of healthcare industries, including pharmaceutical, nutraceutical, infant formula, consumer, medical devices, and diagnostics. Having worked globally and in Australia in healthcare organizations, he brings diverse commercial and scientific understanding to the Company. Robert has held senior executive roles at several pharmaceutical and consumer healthcare entities including Aspen Pharmacare Australia Pty Ltd, Sanofi Australia, and Mayne Group. He has experience in the medicinal cannabis sector, being a former member of the advisory board to Leafcann Group Pty Ltd. He is Chair of the Risk Committee.
    Mr Steven Notaro Company Secretary May 2024
    -
    Tony Di Pietro Chief Financial Officer
    -
    Steven Notaro Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Mr Ryan Prue 14,000,000 3.00%
    Mr Philip Jacobsen & Mrs Maxine Jacobsen 11,478,943 2.46%
    Mullacam Pty Ltd 7,296,023 1.56%
    Flag Capital Pty Ltd 5,876,453 1.26%
    Mr Jiashun Yang 5,253,000 1.12%
    Citicorp Nominees Pty Limited 4,663,983 1.00%
    Supernova Fund Pty Ltd 4,341,363 0.93%
    Invia Custodian Pty Limited 4,040,000 0.86%
    Adsd Soodin Holdings Pty Ltd 3,865,051 0.83%
    Ms Shengyan Hu & Mr Xiangjun Zhao 3,550,000 0.76%
    Mr Christopher John Page 3,500,000 0.75%
    T R Samuels Transport Pty Limited 3,305,817 0.71%
    Cmc Markets Stockbroking Nominees Pty Limited 3,187,043 0.68%
    Mr Michael Anderson 2,524,620 0.54%
    Hsbc Custody Nominees (Australia) Limited 2,475,884 0.53%
    Mr Xuelong Sun 2,463,750 0.53%
    Commonwealth Scientific And Industrial Research Organisation 2,450,338 0.52%
    Pacific Custodians Pty Limited 2,183,068 0.47%
    Hardmail Pty Ltd 2,150,000 0.46%
    Finclear Services Pty Ltd 1,906,633 0.40%

    Profile

    since

    Note